AbbVie

Open: 164.44 Close: 165.39 Change: 0.95

You don't have read the whole internet to decide whether to invest in AbbVie Company Inc Stock. Use an AI.

The game is changing. There is a new strategy to evaluate AbbVie fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, stock, commit, operating, integrity, drive, innovation, and the …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

AbbVie Inc. is committed to operating with integrity, driving innovation, transforming lives, serving our community, and embracing diversity and inclusion. The drugmaker is doubling down on cancer and neurology as it seeks to replace falling revenue from its top sellers.

Today's News

abbvie inc. stock rises monday, outperforms market - marketwatch.com. AbbVies revenue was $58.05 billion, an increase of 3.30%. AbbVie (ABBV) closed at $165.39 in the latest trading session, marking a +0.38% move from the prior day. The drugmaker is doubling down on cancer and neurology as it seeks to replace falling revenue from its top sellers. AbbVie Inc. is committed to operating with integrity, driving innovation, transforming lives, serving our community, and embracing diversity and inclusion. The companys mission is to discover and deliver innovative medicines and solutions. The Senior Counsel, U.S. Government Policy Legal, will be responsible for executing comprehensive legal strategies to build and implement federal and state policy initiatives to support access for AbbVie products in the US. AbbVie is committed to operating with integrity, driving innovation, transforming lives, serving our community, and embracing diversity and inclusion. By submitting your information, you acknowledge you have read those documents. Oncology Account Executive responsible for developing and maintaining strategic business relationships with Oncologists, Hematologists and other departments. Senior Scientist II, Biologics Analytical R&D - Mass Spectrometry Abbvie Irvine, California. The Bioanalytical associate Scientist II will develop and perform bioanalytical assays to quantify botulinum toxin proteins in biological fluids and tissues. The candidate must conduct all work activities in compliance with AbbVie internal and applicable regulatory requirements. Abbvie Inc (ABBV) stock has fallen -0.15%. AbbVie is committed to operating with integrity, driving innovation, transforming lives, serving our community, and embracing diversity and inclusion. ABBVies policy to employ qualified persons of the greatest ability without discrimination. Medical Scientific Liaison, Gastroenterology is a medical scientific Liaison. The role is to assist in building and maintaining relationships with external experts, advancing the scientific credibility of our company. AbbVie is acquiring all outstanding shares of IMGN in a $10.1 billion acquisition deal. Cerevel Therapeutics stock is climbing higher as CERE investors react to an $8.7 billion acquisition. Abbvie expects Botox to maintain its leading market share position. AbbVie and Umoja Biopharma announce two exclusive option and license agreements to develop multiple in-situ generated CAR-T cell therapy candidates in oncology. CVS Health is favoring Humiras biosimilars for its major formularies, with the companys branded product to be nixed on April 1, 2024.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

This document will help you to evaluate AbbVie without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, stock, commit, operating, integrity, drive, innovation, and the most common words in the summary are: abbvie, job, best, stock, get, abbv, market, . One of the sentences in the summary was: AbbVie Inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #job #best #stock #get #abbv #market.